Streetbeat News

Regulatory

MITK

Mitek, a leader in digital identity and fraud prevention, received an extension from the Nasdaq Hearings Panel for continued listing on the Nasdaq Capital Market. The extension is contingent on Mitek filing its Q1 Form 10-Q by April 15, 2024, to comply with Nasdaq Listing Rule 5250(c)(1) and other conditions.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 7:26 am

KGEI

Kolibri Global Energy has been granted a Management Cease Trade Order due to a delay in filing its required financial documents. This regulatory measure restricts the company's management from trading its shares until the necessary filings are completed and reviewed.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 6:50 am

BCS

Barclays Bank announced updates on its comprehensive cash tender offers and consent solicitations for 16 ETN series. This move is part of the bank's broader strategy to manage its financial products and could impact the liquidity and market perception of these ETNs.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 6:09 am

MSFT

The EU's antitrust chief, Margrethe Vestager, has expressed concerns over Microsoft Corporation's acquisition of talent from Inflection AI, including its co-founders. This move, which involved hiring most of Inflection's staff for Microsoft's new AI unit, bypassed traditional regulatory scrutiny. Vestager warned that if such practices become a trend, they could potentially trigger antitrust action. This comes amid the EU's ongoing scrutiny of Microsoft's investment in ChatGPT-parent OpenAI for potential anti-competitive practices.

Portfolio Pulse from Ananya Gairola

April 04, 2024 | 2:36 am

AAPL

AMD

NVDA

TSM

Gene Munster, a tech analyst, highlighted the potential impact of a recent earthquake in Taiwan on AI development due to production challenges at Taiwan Semiconductor Manufacturing Co. (TSMC). The 7.2-magnitude earthquake forced TSMC to halt chip production temporarily, raising concerns about the future of AI as TSMC is a crucial supplier for major companies like Apple, Nvidia, and AMD. Munster's comments draw attention to the vulnerability of AI's development to geopolitical tensions and the importance of diversifying chip manufacturing locations.

Portfolio Pulse from Sudhanshu Singh

April 04, 2024 | 1:26 am

ABAT

AU

FEAM

X

5E Advanced Materials (FEAM) launched operations at its Boron Americas Complex, aiming to produce boric acid and lithium carbonate. Gold Fields (AU) began gold production at Salares Norte, expecting significant output and efficiency. U.S. Steel (X) partnered with CarbonFree to implement CO2 capture technology, supporting low-emission steel production. American Battery Technology (ABAT) received a $20 million grant for battery materials manufacturing and recycling, enhancing U.S. critical material infrastructure.

Portfolio Pulse from Austin DeNoce

April 03, 2024 | 9:23 pm

ZLS

Zalatoris II Acquisition Corp (ZLS) received a notice from Nasdaq on March 28 stating that it has not regained compliance with Nasdaq's rules within the compliance period. Unless ZLS requests an appeal by April 4, its securities will be delisted from Nasdaq. ZLS intends to appeal the determination by requesting a hearing to the hearings panel.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 8:52 pm

IMNM

Immunome Inc has filed a prospectus with the SEC for the proposed resale of 2.3 million shares of common stock by a selling stockholder. This move could potentially impact the stock's liquidity and market perception.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 8:49 pm

EIGR

Eiger Biopharmaceuticals received a notice from Nasdaq on April 2 about the delisting of its common stock, which is expected to start trading on the Over-the-Counter market on April 11, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 8:49 pm

BRBS

Blue Ridge Bankshares, Inc. (BRBS) has successfully closed on a $150 million private placement of common and preferred stock, replacing a previous transaction that failed to meet closing conditions. This capital injection is aimed at repositioning business lines, supporting organic growth, and enhancing capital levels to comply with regulatory requirements. The move comes after a shareholder inquiry raised questions about vote tabulation, prompting a restructuring of the offering.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 8:44 pm